Hypoxia: Clinical Trials

55 trials for Hypoxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed, 14 unknown, 4 recruiting, 4 terminated. 55 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 355Completed 28, Unknown 14, Recruiting 4, Terminated 4, Active not recruiting 2, Not yet recruiting 2, Withdrawn 1
Phase 29Completed 6, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Hypoxia: new trials by email Literature Review of Hypoxia trials Research Report on Hypoxia

Trials (filtered) newest first · largest first

All 55 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy
MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia
Phase 2 / Phase 3Not yet recruitingUMC Utrecht1622027-04-012026-09-21
Caffeine for Hypoxic Ischemic Encephalopathy
Caffeine citrate oral solution, Oral placebo solution - Hypoxic Ischemic Encephalopathy (HIE)
Phase 3RecruitingNICHD Global Network for Women's and Children's Health8302026-04-082026-06-24
Safeguarding the Brain of Our Smallest Children-IIIv (SafeBoosC-IIIv)
Cerebral oximetry monitoring device, Usual care - Hypoxia, Infant, Newborn, Diseases
Phase 3RecruitingCopenhagen Trial Unit, Center for Clinical Intervention Research16102025-04-112025-04-25
Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
Administration of L-TC, Radiotherapy plus Temozolomide - Glioblastoma
Phase 3Not yet recruitingInstitut de cancérologie Strasbourg Europe5542025-01-012024-06-27
Oxygen Targets in Acute Heart Failure With Pulmonary Congestion
Oxygen - Acute Heart Failure, Pulmonary Congestion
Phase 2 / Phase 3CompletedCopenhagen University Hospital, Hvidovre1352024-02-012026-10-26
Effects of Walking Apnea at Low Lung Volume on Hypoalgesia, Cardiovascular Function and Respiratory Function
Voluntary apnoea - Pain, Hypoxia
Phase 3UnknownCentro Universitario La Salle602023-12-012024-01-05
Effects of Walking Apnea at High Lung Volume on Hypoalgesia, Cardiovascular Function and Respiratory Function
Voluntary apnoea - Pain, Hypoxia
Phase 3UnknownCentro Universitario La Salle602023-12-012024-01-05
Effects of Static Apnea at Low Lung Volume on Hypoalgesia, Cardiovascular Function and Respiratory Function
Voluntary apnoea - Pain, Hypoxia
Phase 3UnknownCentro Universitario La Salle602023-12-012024-01-05
Effects of Static Apnea at High Lung Volume on Hypoalgesia, Cardiovascular Function and Respiratory Function
Voluntary apnoea - Pain, Hypoxia
Phase 3UnknownCentro Universitario La Salle602023-12-012024-01-05
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia
UC-MSCs treatment - Mesenchymal Stem Cell, COVID-19 Pneumonia
Phase 3UnknownShanghai East Hospital602023-01-102023-01-18
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Single Arm, Neonatal Neurobehavioral Scale - Congenital Heart Disease in Children, Hypoxia
Phase 2 / Phase 3CompletedUniversity of Utah1042021-12-172026-07-14
Nitric Oxide During Cardiopulmonary Bypass in Adult Surgery
Nitric Oxide, standard of care treatment - Hypoxia
Phase 3UnknownRabin Medical Center3002021-08-142021-10-08
Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD
Acetazolamide, Placebo - Chronic Obstructive Pulmonary Disease, Altitude Sickness
Phase 3UnknownUniversity of Zurich1002021-06-012023-03-03
EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
BEVA+SOC, SOC - Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome)
Phase 3CompletedAssistance Publique - Hôpitaux de Paris962021-04-172022-12-28
Strategy to Avoid Excessive Oxygen in Major Burn Patients
Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg) - Critical Illness, Wounds and Injury
Phase 3Active not recruitingUniversity of Colorado, Denver20002021-04-152025-04-02
Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia
Inhaled Low molecular weight heparin, Standard Treatment - COVID-19 Acute Respiratory Distress Syndrome, Hypoxemia
Phase 2 / Phase 3CompletedIstanbul University802021-02-032021-08-05
CEUS Evaluation of Hypoxic Ischemic Injury
Sulfur hexafluoride lipid-type A microspheres - Hypoxic-Ischemic Encephalopathy, Brain Ischemia Hypoxia
Phase 3CompletedChildren's Hospital of Philadelphia12020-12-012025-05-14
Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients
Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg) - Critical Illness, Wounds and Injury
Phase 3Active not recruitingUniversity of Colorado, Denver60002020-10-152025-04-02
Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia
Dexamethasone - Covid19, Hypoxia
Phase 3CompletedScandinavian Critical Care Trials Group10002020-08-272022-02-24
DAS181 for STOP COVID-19
DAS181, Placebo - COVID-19
Phase 2 / Phase 3WithdrawnAnsun Biopharma, Inc.2020-07-252020-08-11

Showing 20 of 55. Sign in to see all of them.

Narrower conditions

Hypoxia-Ischemia, Brain (14)  ·  Apnea (7)  ·  Hypercapnia (5)  ·  COVID-19 (4)  ·  Pain (4)  ·  Heart Defects, Congenital (3)  ·  Hypoxia, Brain (3)  ·  Asphyxia (2)  ·  Burns (2)  ·  Cardiovascular Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Coronavirus Infections (2)  ·  Critical Illness (2)  ·  Disease Attributes (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (55)  ·  Signs and Symptoms (55)  ·  Signs and Symptoms, Respiratory (55)  ·  Respiratory Tract Diseases (21)  ·  Nervous System Diseases (20)  ·  Brain Diseases (19)  ·  Vascular Diseases (19)  ·  Cardiovascular Diseases (18)  ·  Central Nervous System Diseases (18)  ·  Brain Ischemia (15)  ·  Cerebrovascular Disorders (15)  ·  Respiration Disorders (15)  ·  Hypoxia, Brain (14)  ·  Pathologic Processes (10)

Interventions

Saline Solution (4)  ·  Sodium Chloride (4)  ·  Allopurinol (3)  ·  Mannitol (3)  ·  Hydrocortisone (2)  ·  Radiotherapy (2)  ·  caffeine citrate (2)  ·  hydrocortisone hemisuccinate (2)  ·  Acetazolamide (1)  ·  Budesonide (1)  ·  Capnography (1)  ·  Cardiac Surgical Procedures (1)  ·  Cardiopulmonary Bypass (1)  ·  Cardiopulmonary Resuscitation (1)  ·  Cytidine Diphosphate Choline (1)

Sponsors

Centro Universitario La Salle (4)  ·  Technical University of Munich (4)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  NICHD Global Network for Women's and Children's Health (2)  ·  Scandinavian Critical Care Trials Group (2)  ·  UMC Utrecht (2)  ·  University of Colorado, Denver (2)  ·  American SIDS Institute (1)  ·  Ansun Biopharma, Inc. (1)  ·  Armed Forces Hospital, Pakistan (1)  ·  Assiut University (1)  ·  Boston Children's Hospital (1)  ·  Burnasyan Federal Medical Biophysical Center (1)  ·  Children's Hospital of Philadelphia (1)  ·  Copenhagen Trial Unit, Center for Clinical Intervention Research (1)

Countries

United States (11)  ·  Germany (7)  ·  Spain (6)  ·  Denmark (4)  ·  France (4)  ·  Netherlands (4)  ·  Belgium (3)  ·  China (2)  ·  India (2)  ·  Italy (2)  ·  Pakistan (2)  ·  Russia (2)  ·  Switzerland (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)

Top investigators

Adit Ginde, MD, MPH (2)  ·  Stefan von Delius, MD (2)  ·  Abbot R. Laptook, MD (1)  ·  Abhik Das, PhD (1)  ·  Aida A. Yakupova, MD, Cand.Med.Sci (1)  ·  Aleksandr Y. Malygin, MD, Dr.Med.Sci (1)  ·  Alina S. Agafina, MD, Cand.Med.Sci (1)  ·  Amanda Peppercorn, MD (1)  ·  Anders Perner, MD, PhD (1)  ·  Andrey M. Alasheev, MD, Dr.Med.Sci (1)  ·  Anne Smits, MD, PhD (1)  ·  Axel Franz, Prof. Dr. (1)  ·  Ayca Yildiz-Pekoz, PhD (1)  ·  Barbara J. Stoll, MD (1)  ·  Bart Lambrecht, MD, PhD (1)

Results publications

PMID 12165594, PMID 16221780, PMID 17079582, PMID 18534246, PMID 18720323, PMID 18762517, PMID 18829776, PMID 19020525, PMID 19252411, PMID 19564319, PMID 19834012, PMID 19948631, PMID 20921569, PMID 21054515, PMID 21852153, PMID 21875911, PMID 22646631, PMID 24019415, PMID 24352085, PMID 24445955, PMID 25512466, PMID 26387012, PMID 26415090, PMID 27776752, PMID 28249612, PMID 28606907, PMID 29866165, PMID 30138355, PMID 30808770, PMID 31155392, PMID 3124102, PMID 32493441, PMID 32738928, PMID 33038899, PMID 33138837, PMID 33493423, PMID 33583027, PMID 33935163, PMID 34138478, PMID 34673895, PMID 34749762, PMID 34756178, PMID 34757439, PMID 35067914, PMID 35080773, PMID 35349129, PMID 35359168, PMID 35835616, PMID 37316785, PMID 38267942

NIH funding

1UG3HL141722-01A1 (1), 2016 (1), 2017 (1), 2019 (1), 2025 (1), M01RR000030 (1), M01RR000039 (1), M01RR000044 (1), M01RR000070 (1), M01RR000080 (1), M01RR000633 (1), M01RR000750 (1), M01RR006022 (1), M01RR007122 (1), M01RR008084 (1)